Professional Documents
Culture Documents
PHARMACOLOGICAL DE-RESUSCITATION
Yohanes George
WHEN SHOULD DE-RESUSCITATION BEGIN?
• DE-RESUSCITATION SHOULD BE CONSIDERED WHEN FLUID OVERLOAD AND FLUID
ACCUMULATION NEGATIVELY IMPACT END-ORGAN FUNCTION.
• DE-RESUSCITATION IS MANDATORY IN A CASE OF A POSITIVE CUMULATIVE FLUID
BALANCE IN COMBINATION WITH:
• POOR OXYGENATION (P/F RATIO < 200),
• INCREASED CAPILLARY LEAK (HIGH PVPI > 2.5 AND EVLWI > 12 ML KG-1 PBW),
• INCREASED IAP (> 15 MM HG) AND HIGH CLI
WHEN SHOULD DE-RESUSCITATION BEGIN?
EBB PHASE: AFTER RESUSCITATION
FLUID OVERLOAD
Lung Edema: PaO2/FiO2, prolong weaning
ACS: Abd Compartment Syndrome
DIURESIS RESPONSIVENESS:
FUROSEMIDE STRESS TEST; BOLUS LASIX 1-1.5/Kg
DERESUSCITATION DERESUSCITATION
NON-PHARMACOLOGY (HD-CRRT) PHARMACOLOGY (DIURETIC)
FLOW PHASE:
FLUID MOBILISATION:
Creatinin , Diuresis
Edema resolution
Weaning ventilation
DOKUMEN ACUTE DIALYSIS QUALITY INITIATIVE
(ADQI) XII TAHUN 2014
Protokol deresusitasi yang aman dengan mengunakan:
1. Target endpoint physiology
1. target klinis (resolusi edema, perbaikan oksigenasi paru)
2. Target fluid balans 24 jam – 1 Liter (20%)
2. Target safety perfusion.
1. lactate darah
2. Target fungsi ginjal, peningkatan ureum dan creatinin <25% dan
3. Target perubahan Na < 4 mmol/L.
Sebagai contoh jika target klinis dan fluid balance belum tercapai namun
target keamanan perfusi dan ginjal masih dalam batas aman maka
deresusitasi di lanjutkan, namun jika target klinis dan fluid balance belum
tercapai namun target kemanan perfusi atau fungsi ginjal mulai di lewati
maka deresusitasi di stop.
S. Goldstein, S. Bagshaw, M. Cecconi, M. Okusa, H. Wang, J. Kellum, M. Mythen and A. D. Shaw for the ADQI XII Investigators
Group. Pharmacological management of fluid overload. British Journal of Anaesthesia 113 (5): 756–63 (2014).
Target balance negatif belum tercapai, Lasik RRT
masih edema, oksigenasi masih buruk
A Novel strategy of
resuscitation for
severe capillary
leakage
syndrome??Severe
Dengue
haemorrhagic fever.
1.Resuscitation
phase (12 hours):
Blood components +
500 ml of alb 5%.
2.Conservative fluid
removal 2nd day,
furosemide drip with
target %FO<10%.
Lowering CVP with furosemide drip infusion 0.1 mg/kg/hr will increase venous return
by increasing the gradient pressure between CVP and MCFP.
CONCLUSION
• The dosage and timing of pharmacological fluid measures may depend upon the
relative level of Fluid Overload, the targeted and actual rates of active fluid
removal and underlying kidney function.
• In a patient fully resuscitated from septic shock with intact kidney function,
urine output may be adequate to allow early tapering or discontinuation of
pharmacological measures.
• In urgency case, the rate of fluid removal, prompting clinicians to plan a more
rapid fluid removal trajectory, perhaps with the use of extracorporeal therapy.
• An active pharmacological de-resuscitation strategy based on the achievement
of negative fluid balance is a safe and effective procedure that resulted in
improvement in hemodynamics, serum lactate, renal function and also systemic
oxygenation